Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grupo Español De Investigación En Neurooncología

Clinical trials sponsored by Grupo Español De Investigación En Neurooncología, explained in plain language.

Trials to join now! 1 Completed 1

New drug tuvusertib targets recurrent brain tumors in phase 2 trial

Disease control Recruiting now

This phase 2 trial tests the drug tuvusertib in 56 adults with recurrent IDH-mutant astrocytoma, a type of brain tumor. Participants take tuvusertib daily for two weeks, then one week off. The main goal is to see if the drug can improve the number of patients whose cancer does no…

Phase: PHASE2 • Sponsor: Grupo Español de Investigación en Neurooncología • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC